Search
for
Sort by
Research 121–150 of 1000+
- Transcriptome sequencing reveals the expression profiles of lncRNAs and mRNAs in goat skin tissues with different types of wool coats
- Macrophages as central mediators of sympathetic neuro-immune interplay in autoimmunity
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- Maternal western diet causes inflammatory milk and TLR2/4-dependent neonatal toxicity
- Toll-like receptor-targeted anti-tumor therapies: Advances and challenges
- Applications of Marine Organism-Derived Polydeoxyribonucleotide: Its Potential in Biomedical Engineering
- Altered expression of intracellular Toll-like receptors in peripheral blood mononuclear cells from patients with alopecia areata
- In silico analysis of ethyl acetate Bruguiera gymnorhiza leaf extracts as an anti-inflammatory agent
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris
- 033 IL-15 is an unexpected guardian of hair follicle immune privilege and promotes human hair growth ex vivo
- Dupilumab: Friend or Foe to Alopecia Areata?
- 455 Molecular correlation with clinical outcomes in an open label clinical trial of oral tofacitinib in patients with alopecia areata
- GPCRs as key regulators in wound healing
- The role of fibroblast growth factor receptor 2b in skin homeostasis and cancer development
- Lichen Planopilaris Treated With a Peroxisome Proliferator–Activated Receptor γ Agonist
- Lichen Planopilaris and Frontal Fibrosing Alopecia as Model Epithelial Stem Cell Diseases
- Constitutive Internalization of the Leucine-rich G Protein-coupled Receptor-5 (LGR5) to the Trans-Golgi Network
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Targeted Treatments of Non-Small Cell Lung Cancer (NSCLC): Skin Toxicity
- Common Skin Diseases and Metabolic Syndrome: A Proinflammatory Chemokine Perspective
- Prostaglandin E <sub>2</sub> Receptor 2 Modulates Macrophage Activity for Cardiac Repair
- Thyroxine (T4) may promote re-epithelialisation and angiogenesis in wounded human skin ex vivo
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Accelerative action of topical piperonylic acid on mice full thickness wound by modulating inflammation and collagen deposition
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Role of Metformin in Acanthosis Nigricans
- Chitinase 3-Like 1 and C-X-C motif chemokine ligand 5 proteins and the hair cycle
- Dermatologic Reactions to Targeted Therapy